Save time and jump to the most important pieces.
Date | Price Target | Rating | Analyst |
---|---|---|---|
12/6/2023 | Mkt Perform | JMP Securities | |
11/3/2023 | $32.00 → $21.00 | Buy → Hold | Jefferies |
6/26/2023 | Outperform | William Blair | |
3/10/2023 | $30.00 | Buy | Loop Capital |
10/5/2022 | $36.00 | Buy → Hold | Truist |
2/24/2022 | $33.00 → $42.00 | Buy | Benchmark |
1/27/2022 | $18.00 → $27.00 | Hold → Buy | Jefferies |
8/16/2021 | $13.50 → $19.00 | Neutral | Credit Suisse |
SC 13G/A - CROSS COUNTRY HEALTHCARE INC (0001141103) (Subject)
SC 13G/A - CROSS COUNTRY HEALTHCARE INC (0001141103) (Subject)
SC 13G/A - CROSS COUNTRY HEALTHCARE INC (0001141103) (Subject)
Cross Country Healthcare, Inc. (NASDAQ:CCRN) will hold its quarterly conference call to discuss its third quarter 2024 financial results on Wednesday, November 6, 2024 at 5:00 p.m. Eastern Time. Cross Country Healthcare, Inc. (the "Company") intends to distribute its earnings press release after market close on Wednesday, November 6, 2024. This call will be webcast live and can be accessed at the Company's website at ir.crosscountry.com or by dialing 888-566-1290 from anywhere in the U.S. or by dialing 773-799-3776 from non-U.S. locations – Passcode: Cross Country. A replay of the webcast will be available from November 6th through November 20th on the Company's website and a replay of the
Cross Country Healthcare, Inc. (the "Company") (NASDAQ:CCRN) today announced financial results for its second quarter ended June 30, 2024. SELECTED FINANCIAL INFORMATION: Variance Variance Q2 2024 vs Q2 2024 vs Dollars are in thousands, except per share amounts Q2 2024 Q2 2023 Q1 2024 Revenue $ 339,771 (37 ) % (10 ) % Gross profit margin* 20.8 % (200 ) bps 40 bps Net (loss) income attributable to common stockh
Cross Country Healthcare, Inc. (NASDAQ:CCRN) will hold its quarterly conference call to discuss its second quarter 2024 financial results on Wednesday, July 31, 2024 at 5:00 p.m. Eastern Time. Cross Country Healthcare, Inc. (the "Company") intends to distribute its earnings press release after market close on Wednesday, July 31, 2024. This call will be webcast live and can be accessed at the Company's website at ir.crosscountry.com or by dialing 888-566-1290 from anywhere in the U.S. or by dialing 773-799-3776 from non-U.S. locations – Passcode: Cross Country. A replay of the webcast will be available from July 31st through August 14th on the Company's website and a replay of the conferen
10-Q - CROSS COUNTRY HEALTHCARE INC (0001141103) (Filer)
8-K - CROSS COUNTRY HEALTHCARE INC (0001141103) (Filer)
8-K - CROSS COUNTRY HEALTHCARE INC (0001141103) (Filer)
Cross Country Healthcare, Inc. (the "Company") (NASDAQ:CCRN) announced today that it is scheduled to participate in the UBS Global Healthcare Conference taking place November 11-14, 2024 at the Terranea Resort Hotel in Rancho Palos Verdes, CA. John Martins, President & Chief Executive Officer and Josh Vogel, Vice President, Investor Relations will participate in one-on-one investor meetings on Wednesday, November 13. No formal presentation will be made. About Cross Country Healthcare Cross Country Healthcare, Inc. is a market-leading, tech-enabled workforce solutions and advisory firm with 38 years of industry experience and insight. We help clients tackle complex labor-related challenges
Cross Country Healthcare, Inc. (NASDAQ:CCRN) will hold its quarterly conference call to discuss its third quarter 2024 financial results on Wednesday, November 6, 2024 at 5:00 p.m. Eastern Time. Cross Country Healthcare, Inc. (the "Company") intends to distribute its earnings press release after market close on Wednesday, November 6, 2024. This call will be webcast live and can be accessed at the Company's website at ir.crosscountry.com or by dialing 888-566-1290 from anywhere in the U.S. or by dialing 773-799-3776 from non-U.S. locations – Passcode: Cross Country. A replay of the webcast will be available from November 6th through November 20th on the Company's website and a replay of the
NEW YORK, Sept. 26, 2024 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P SmallCap 600 and S&P MidCap 400: S&P SmallCap 600 constituent The Ensign Group Inc. (NASD: ENSG) will replace Southwestern Energy Co. (NYSE:SWN) in the S&P MidCap 400 and TransMedics Group, Inc. (NASD: TMDX) will replace The Ensign Group in the S&P SmallCap 600 effective prior to the opening of trading on Tuesday, October 1. S&P MidCap 400 constituent Chesapeake Energy Corp. (NASD: CHK) is acquiring Southwestern Energy in a deal expected to be completed October 1.Curbline Properties Corp. (NYSE:CURB) will be added to the S&P SmallCap 600 effective prior to the open of trading on Tuesda
NEW YORK, Sept. 26, 2024 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P SmallCap 600 and S&P MidCap 400: S&P SmallCap 600 constituent The Ensign Group Inc. (NASD: ENSG) will replace Southwestern Energy Co. (NYSE:SWN) in the S&P MidCap 400 and TransMedics Group, Inc. (NASD: TMDX) will replace The Ensign Group in the S&P SmallCap 600 effective prior to the opening of trading on Tuesday, October 1. S&P MidCap 400 constituent Chesapeake Energy Corp. (NASD: CHK) is acquiring Southwestern Energy in a deal expected to be completed October 1.Curbline Properties Corp. (NYSE:CURB) will be added to the S&P SmallCap 600 effective prior to the open of trading on Tuesda
Cross Country Healthcare, Inc., (NASDAQ:CCRN), a leading provider of advisory and workforce solutions including contingent staffing, permanent placement, and other consultative services for healthcare clients, has appointed Phillip Noe to the role of Chief Information Officer (CIO). Noe replaces Bill Halnon who is retiring, and will report directly to Kevin C. Clark, Co-founder and CEO. He commences May 10, 2021. "Phil's appointment reflects the ongoing evolution of our digital transformation at Cross Country," said Kevin C. Clark, Co-founder and Chief Executive Officer of Cross Country Healthcare. "His extensive experience in information technology spans every aspect of the software engin
Barrington Research analyst Kevin Steinke maintains Cross Country Healthcare (NASDAQ:CCRN) with a Outperform and lowers the price target from $24 to $21.
Throughout the last three months, 4 analysts have evaluated Cross Country Healthcare (NASDAQ:CCRN), offering a diverse set of opinions from bullish to bearish. The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 2 1 1 0 0 Last 30D 1 0 0 0 0 1M Ago 0 0 0 0 0 2M Ago 0 0 0 0 0 3M Ago 1 1 1 0 0 Insights from analysts' 12-month price targets are revealed, presenting an average target of $20.0, a high estimate of $24.00, and a low estimate of $16.00. This current average has decrease
Benchmark analyst Bill Sutherland maintains Cross Country Healthcare (NASDAQ:CCRN) with a Buy and lowers the price target from $21 to $19.
4 - CROSS COUNTRY HEALTHCARE INC (0001141103) (Issuer)
4 - CROSS COUNTRY HEALTHCARE INC (0001141103) (Issuer)
4 - CROSS COUNTRY HEALTHCARE INC (0001141103) (Issuer)
JMP Securities initiated coverage of Cross Country with a rating of Mkt Perform
Jefferies downgraded Cross Country from Buy to Hold and set a new price target of $21.00 from $32.00 previously
William Blair initiated coverage of Cross Country with a rating of Outperform